Measurable Residual Disease Monitoring in Lymphoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Link
https://link.springer.com/content/pdf/10.1007/s11899-023-00715-6.pdf
Reference102 articles.
1. Cheson BD, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–67. https://doi.org/10.1200/jco.2013.54.8800.
2. Ansell SM, Armitage JO. Positron emission tomographic scans in lymphoma: convention and controversy. Mayo Clin Proc. 2012;87:571–80. https://doi.org/10.1016/j.mayocp.2012.03.006.
3. Scherer F, et al. High-throughput sequencing for noninvasive disease detection in hematologic malignancies. Blood. 2017;130:440–52. https://doi.org/10.1182/blood-2017-03-735639.
4. Taylor SC, Laperriere G, Germain H. Droplet digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication Quality Data. Sci Rep. 2017:7. https://doi.org/10.1038/s41598-017-02217-x.
5. •Ching T, et al. Analytical evaluation of the CLONOSEQ assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma. BMC Cancer. 2020;20 https://doi.org/10.1186/s12885-020-07077-9. Provides evidence for the justification of using ClonoSeq for MRD monitoring in a variety of hematologic malignancies. This was the first FDA approved NGS-based assay for this indication and remains a commonly utilized tool for this purpose.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3